Delcath Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Delcath Systems, Inc. (Nasdaq: DCTH) (the "Company" or "Delcath"), an interventional oncology company focused on the treatment of primary and...

PR NewswireApr 4 20:35

Delcath Systems, Inc. (NASDAQ:DCTH) Q4 2023 Earnings Call Transcript

Yahoo FinanceMar 27 23:35

Netflix To Rally Over 15%? Here Are 10 Top Analyst Forecasts For Wednesday

Netflix To Rally Over 15%? Here Are 10 Top Analyst Forecasts For Wednesday

BenzingaMar 27 20:40

Delcath Systems Price Target Raised to $20.00/Share From $18.00 by HC Wainwright & Co.

Delcath Systems Price Target Raised to $20.00/Share From $18.00 by HC Wainwright & Co.

Dow JonesMar 27 18:35

HC Wainwright & Co. Maintains Buy on Delcath Systems, Raises Price Target to $20

HC Wainwright & Co. analyst Swayampakula Ramakanth maintains Delcath Systems with a Buy and raises the price target from $18 to $20.

Analyst UpgradesMar 27 18:24

Delcath Systems Analyst Ratings

Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 03/27/2024 338.6% HC Wainwright & Co. $18 → $20 Maintains Buy 09/07/2023 360.53% Canaccord Genuity $18 → $

BenzingaMar 27 18:23